Myeloid-ILK deficiency also enhances tumour-infiltration of CD8+ T cells and reduces FOXP3+ T cells in CAC and APCmin/+-driven CRC, respectively, with a significantly elevated CD8+/FOXP3+ ratio indicating a tumoricidal impact in both models. The gene discussed is ILK; the disease is neoplasm.